S. Matzk

发表

Predictive analysis of metabolic and preventive patient data

S. Matzk, 2018 .

Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.

Takafumi N. Yamaguchi, C. von Kalle, R. Eils, 2018, Cancer cell.

Molecular Evolution of Ear ly-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories Graphical

Takafumi N. Yamaguchi, R. Eils, J. Korbel, 2018 .

The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability.

M. Yaspo, V. Amstislavskiy, M. Schrappe, 2019, Cancer cell.

Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

P. Campbell, P. Vyas, E. Papaemmanuil, 2019, Cancer cell.

Erratum: Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome (Cancer Cell (2019) 36(2) (123–138.e10), (S1535610819302983), (10.1016/j.ccell.2019.06.007))

P. Campbell, P. Vyas, E. Papaemmanuil, 2019 .

Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

P. Campbell, P. Vyas, E. Papaemmanuil, 2019, Cancer cell.

RUNX1 isoform disequilibrium in the development of trisomy 21 associated myeloid leukemia

M. Yaspo, D. Heckl, D. Reinhardt, 2022, bioRxiv.

RUNX1 isoform disequilibrium promotes the development of trisomy 21–associated myeloid leukemia

M. Yaspo, D. Heckl, M. Ng, 2022, Blood.